Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M18,247Revenue (TTM) $M22,385Net Margin (%)-72.7Altman Z-Score-0.4
Enterprise Value $M54,776EPS (TTM) $-16.3Operating Margin %-78.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.9Pre-tax Margin (%)-82.1Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.85-y EBITDA Growth Rate %--Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow6.9y-y EBITDA Growth Rate %-603.2ROA % (ttm)-19.0Higher Current Ratio y-yN
Dividend Yield %4.8PEG--ROE % (ttm)-58.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M1,017ROIC % (ttm)-22.8Gross Margin Increase y-yN

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

TEVA is held by these investors:

TEVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stark David MatthewExec. VP Chief Legal Officer 2018-03-12Sell2,441$19.2-7.6view
O'Grady Brendan P.EVP, North America Commercial 2018-03-12Sell738$19.49-8.98view
Nazzi GianfrancoEVP, Growth Markets Commercial 2018-03-12Sell461$19.5-9.03view
Griffin Deborah AChief Accounting Officer 2018-03-12Sell952$19.49-8.98view
Dethlefs SvenEVP Global Marketing&Portfolio 2018-03-12Sell576$19.49-8.98view
Daniell RichardExec. VP, European Commercial 2018-03-12Sell714$19.5-9.03view
O'Grady Brendan P.EVP, North America Commercial 2018-03-05Sell705$19.38-8.46view
Griffin Deborah AChief Accounting Officer 2018-03-05Sell773$19.38-8.46view
Daniell RichardExec. VP, European Commercial 2018-03-05Sell1,108$19.28-7.99view
Sabag MarkEVP, Global Human Resources 2018-02-15Sell5,050$19.68-9.86view

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    Berkshire's 4th Quarter Buy Teva Appears Cheap and Troubled Feb 23 2018 
    Einhorn Discusses Worst Ever Performance for Greenlight Feb 21 2018 
    Muhlenkamp & Co. 4th Quarter 2017 Shareholder Letter Feb 21 2018 
    Should You Follow Buffett Into Teva Pharmaceutical? Feb 20 2018 
    Francis Chou Nearly Dumps Entire Stake in Valeant, Teva and Overstock in 4th Quarter Feb 16 2018 
    Three Stocks Are Advancing Feb 15 2018 
    Warren Buffett’s Berkshire Buys Teva, Apple and Slashes IBM Feb 14 2018 
    Francisco Garcia Parames Buys 19 Stocks in 4th Quarter Feb 09 2018 
    Francisco Garcia Parames' Cobas Asset Management Comments on Fourth Quarter 2017 Feb 09 2018 
    Teva Is Playing Debt Roulette and It May Just Work Feb 02 2018 

    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat